Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the NLRP3 Inflammasome in Neuroinflammation: Health Promoting Effects of Dietary Phytochemicals in Neurological Disorders
Wei‐Lun Hung, Chi‐Tang Ho, Min‐Hsiung Pan
Molecular Nutrition & Food Research (2019) Vol. 64, Iss. 4
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression
Haixia Wang, Yi He, Zuoli Sun, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 274
New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation
Triveni Kodi, Runali Sankhe, Adarsh Gopinathan, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 24
The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets
Rongrong Bai, Yue Lang, Jie Shao, et al.
ASN NEURO (2021) Vol. 13, pp. 175909142110181-175909142110181
Open Access | Times Cited: 61
Resveratrol Inhibits NLRP3 Inflammasome-Induced Pyroptosis and miR-155 Expression in Microglia Through Sirt1/AMPK Pathway
Kemal Uğur Tüfekçi, Bedir Irem Eltutan, Kamer Burak Isci, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 6, pp. 1812-1829
Closed Access | Times Cited: 56
MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes
Saba Bakhshi, Saeedeh Shamsi
International Immunopharmacology (2022) Vol. 106, pp. 108595-108595
Closed Access | Times Cited: 52
Neuroprotective Effects of Phytochemicals against Aluminum Chloride-Induced Alzheimer’s Disease through ApoE4/LRP1, Wnt3/β-Catenin/GSK3β, and TLR4/NLRP3 Pathways with Physical and Mental Activities in a Rat Model
Ahmed M. Hamdan, Fatimah Hussain J. Alharthi, Ahmed Hadi Alanazi, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1008-1008
Open Access | Times Cited: 38
Exploring the mechanisms of kaempferol in neuroprotection: Implications for neurological disorders
Amir Mohammad Nezhad Salari, Zahra Rasoulizadeh, Arezoo Gowhari Shabgah, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 13
The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases
Ya-Shuo Feng, Zixuan Tan, Linyu Wu, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111428-111428
Open Access | Times Cited: 41
Fluoxetine ameliorates Alzheimer’s disease progression and prevents the exacerbation of cardiovascular dysfunction of socially isolated depressed rats through activation of Nrf2/HO-1 and hindering TLR4/NLRP3 inflammasome signaling pathway
Karema Abu‐Elfotuh, Aya H. Al‐Najjar, Asmaa A. Mohammed, et al.
International Immunopharmacology (2022) Vol. 104, pp. 108488-108488
Closed Access | Times Cited: 34
Ginsenosides Rb1 Attenuates Chronic Social Defeat Stress-Induced Depressive Behavior via Regulation of SIRT1-NLRP3/Nrf2 Pathways
Ning Jiang, Yiwen Zhang, Caihong Yao, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 31
Thymus vulgaris, a natural pharmacy against COVID-19: A molecular review
A. Nadi, Amir Abbas Shiravi, Zahra Mohammadi, et al.
Journal of Herbal Medicine (2023) Vol. 38, pp. 100635-100635
Open Access | Times Cited: 18
1,2,4-Trimethoxybenzene ameliorates depression-like behaviors by inhibiting the activation of NLRP3 inflammasome
Yang Zhang, Na Che, Bo Wang, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114361-114361
Closed Access
Dietary EPA‐Enriched Phospholipids Alleviate Chronic Stress and LPS‐Induced Depression‐ and Anxiety‐Like Behavior by Regulating Immunity and Neuroinflammation
Chengcheng Wang, Lei Du, Teruyoshi Yanagita, et al.
Molecular Nutrition & Food Research (2021) Vol. 65, Iss. 17
Closed Access | Times Cited: 38
Ginsenoside Re protects against chronic restraint stress‐induced cognitive deficits through regulation of NLRP3 and Nrf2 pathways in mice
Haixia Wang, Jingwei Lv, Ning Jiang, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 5, pp. 2523-2535
Closed Access | Times Cited: 37
Inhibitory effects of sulforaphane on NLRP3 inflammasome activation
Cagla Kiser, Ceren Perihan Gonul, Melis Olcum, et al.
Molecular Immunology (2021) Vol. 140, pp. 175-185
Closed Access | Times Cited: 35
Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases
Nadire Özenver, Thomas Efferth
Pharmacological Research (2021) Vol. 170, pp. 105710-105710
Closed Access | Times Cited: 32
Ginsenoside Rd reverses cognitive deficits by modulating BDNF-dependent CREB pathway in chronic restraint stress mice
Haixia Wang, Ning Jiang, Jingwei Lv, et al.
Life Sciences (2020) Vol. 258, pp. 118107-118107
Closed Access | Times Cited: 37
Modulatory Properties of Food and Nutraceutical Components Targeting NLRP3 Inflammasome Activation
Mattia Spano, Giacomo Di Matteo, Cinzia Ingallina, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 490-490
Open Access | Times Cited: 20
Beneficial effects of flavonoids on cardiovascular diseases by influencing NLRP3 inflammasome
Haiyan Fang, Xiao-ni Zhao, Meng Zhang, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1715-1729
Closed Access | Times Cited: 10
Sinomenine Alleviates Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis through Inhibiting NLRP3 Inflammasome
Zahra Kiasalari, Siamak Afshin‐Majd, Tourandokht Baluchnejadmojarad, et al.
Journal of Molecular Neuroscience (2020) Vol. 71, Iss. 2, pp. 215-224
Closed Access | Times Cited: 29
Nano-engineered nerolidol loaded lipid carrier delivery system attenuates cyclophosphamide neurotoxicity – Probable role of NLRP3 inflammasome and caspase-1
Ashif Iqubal, Mansoor Ali Syed, Abul Kalam Najmi, et al.
Experimental Neurology (2020) Vol. 334, pp. 113464-113464
Closed Access | Times Cited: 28
Inhibition of microglial receptor‐interacting protein kinase 1 ameliorates neuroinflammation following cerebral ischaemic stroke
Yang Jiao, Jianjian Wang, Huixue Zhang, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 21, pp. 12585-12598
Open Access | Times Cited: 27
Exploring the mechanism of Suanzaoren decoction in treatment of insomnia based on network pharmacology and molecular docking
Shuxiao Wang, Zhao Yan, Xingang Hu
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Unraveling the mechanistic interplay of mediators orchestrating the neuroprotective potential of harmine
Pankaj Kadyan, Lovedeep Singh
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 665-678
Closed Access | Times Cited: 2
<p>Spinal TLR4/P2X7 Receptor-Dependent NLRP3 Inflammasome Activation Contributes to the Development of Tolerance to Morphine-Induced Antinociception</p>
Haiyan Wang, Yu Zhang, Xiaqing Ma, et al.
Journal of Inflammation Research (2020) Vol. Volume 13, pp. 571-582
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top